Last reviewed · How we verify

NCT03971968

Observational Study for the Long-Term Effects of a Dermal Substitute on Patients With Facial Burns.

Completed Last updated 3 June 2019
What this trial tests

trial testing Skin replacement with artificial skin in Cicatrix in 8 participants. Completed in 14 February 2019.

Timeline
31 January 2019
Primary endpoint
14 February 2019
14 February 2019

Quick facts

Lead sponsorUniversitair Ziekenhuis Brussel
StatusCompleted
Study typeOBSERVATIONAL
Enrollment8
Start date31 January 2019
Primary completion14 February 2019
Estimated completion14 February 2019
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Universitair Ziekenhuis Brussel — full company profile →

Who can join

Adults 18 to 75, any sex, with Cicatrix. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observational study is to investigate the long-term (between 10-20 years) results for the surgical treatment of third degree burn injury in the face and/or the neck by means of Integra® Dermal Regeneration Template. This study is an observational case-control study. The healthy skin of a comparable and/or contralateral skin-site of the face/neck serves as a comparator. The population consists of human volunteers between 18 and 75 years old with third degree full thickness burn injuries in the face and/or neck, who underwent surgical treatment with IDRT between 1998 and 2008.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical Measurement of Transepidermal Water Loss.
    Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148

Verify or expand the search:

Other recruiting trials for Cicatrix

Currently open trials in the same condition.

Other Universitair Ziekenhuis Brussel trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03971968.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing